Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on synovitis.

Z Szekanecz1, A E Koch

  • 1Department of Medicine, Division of Arthritis and Connective Tissue Diseases, Northwestern University Medical School, Ward Building 3-315, 303 East Chicago Avenue, Chicago, IL 60611, USA.

Current Rheumatology Reports
|March 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.

Seminars in arthritis and rheumatism·2022
Same author

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial.

Scandinavian journal of rheumatology·2019
Same author

Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment.

Lupus·2018
Same author

Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Annals of the rheumatic diseases·2016
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
Same journal

Management of IgG4-Related Disease.

Current rheumatology reports·2026
See all related articles

Rheumatoid arthritis (RA) involves chronic synovitis, leading to joint damage. This review details RA pathogenesis, focusing on inflammatory mechanisms and potential immunotherapies for this complex joint disorder.

Area of Science:

  • Immunology and Rheumatology
  • Cell Biology
  • Pathogenesis of Joint Disorders

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory condition characterized by synovitis.
  • Synovitis involves the activation of synovial lining cells, macrophages, endothelial cells, lymphocytes, and fibroblasts.
  • RA leads to progressive destruction of cartilage and bone within the joints.

Purpose of the Study:

  • To review and update the understanding of key mechanisms underlying synovitis in rheumatoid arthritis.
  • To discuss the roles of inflammatory cells, cell surface molecules, and soluble mediators in RA pathogenesis.
  • To explore current and future immunotherapy strategies for inflammatory synovitis.

Main Methods:

  • Comprehensive literature review of existing research on rheumatoid arthritis pathogenesis.

Related Experiment Videos

  • Analysis of cellular and molecular mechanisms involved in chronic synovitis.
  • Evaluation of data from animal and human trials on immunotherapy.

    • Main Results:

    • Synovitis involves complex interactions including inflammatory cell adhesion, mediator production (cytokines, chemokines, growth factors), angiogenesis, joint destruction, fibrosis, and bone resorption.
    • Specific cell types and soluble mediators play critical roles in driving the inflammatory cascade.
    • Immunotherapy approaches show promise in targeting key pathways of inflammatory synovitis.

    Conclusions:

    • Understanding the intricate mechanisms of synovitis is crucial for developing effective treatments for rheumatoid arthritis.
    • Targeting specific inflammatory pathways and cellular interactions offers potential therapeutic strategies.
    • Ongoing research and clinical trials are vital for advancing immunotherapy for RA.